Butyrylcholinesterase for Protection from Organophosphorus Poisons: Catalytic Complexities and Hysteretic Behavior

Overview

Journal Arch Biochem Biophys

Publisher Elsevier

Specialties Biochemistry
Biophysics

Date 2009 Dec 17

PMID 20004171

Citations 66

Authors

Patrick Masson

Oksana Lockridge

Affiliations

Soon will be listed here.

Abstract

Butyrylcholinesterase is a promiscuous enzyme that displays complex kinetic behavior. It is toxicologically important because it detoxifies organophosphorus poisons (OP) by making a covalent bond with the OP. The OP and the butyrylcholinesterase are both inactivated in the process. Inactivation of butyrylcholinesterase has no adverse effects. However, inactivation of acetylcholinesterase in nerve synapses can be lethal. OP-inhibited butyrylcholinesterase and acetylcholinesterase can be reactivated with oximes provided the OP has not aged. Strategies for preventing the toxicity of OP include (a) treatment with an OP scavenger, (b) reaction of non-aged enzyme with oximes, (c) reactivation of aged enzyme, (d) slowing down aging with peripheral site ligands, and (e) design of mutants that rapidly hydrolyze OP. Option (a) has progressed through phase I clinical trials with human butyrylcholinesterase. Option (b) is in routine clinical use. The others are at the basic research level. Butyrylcholinesterase displays complex kinetic behavior including activation by positively charged esters, ability to hydrolyze amides, and a lag time (hysteresis) preceding hydrolysis of benzoylcholine and N-methylindoxyl acetate. Mass spectrometry has identified new OP binding motifs on tyrosine and lysine in proteins that have no active site serine. It is proposed, but not yet proven, that low dose exposure involves OP modification of proteins that have no active site serine.

Citing Articles

Applications of Microbial Organophosphate-Degrading Enzymes to Detoxification of Organophosphorous Compounds for Medical Countermeasures against Poisoning and Environmental Remediation.

Pashirova T, Salah-Tazdait R, Tazdait D, Masson P Int J Mol Sci. 2024; 25(14).

PMID: 39063063 PMC: 11277490. DOI: 10.3390/ijms25147822.

Acetylcholinesterase and butyrylcholinesterase co-immobilized on a copper containing Prussian blue modified electrode for the broad screening of insecticides.

Bucur M, Radulescu M, Bucur B, Radu G Anal Bioanal Chem. 2024; 416(23):5059-5070.

PMID: 39009770 DOI: 10.1007/s00216-024-05443-1.

Study of multifunctional anti-AD ligands: design, synthesis, X-ray crystal structure and biological evaluation of diosmetin derivatives.

Yang A, Yi X, Zhang H, Chen Q, Shen R, Kou X Mol Divers. 2024; 29(2):1323-1335.

PMID: 38935304 DOI: 10.1007/s11030-024-10913-w.

Emerging significance of butyrylcholinesterase.

Sridhar G, Gumpeny L World J Exp Med. 2024; 14(1):87202.

PMID: 38590305 PMC: 10999061. DOI: 10.5493/wjem.v14.i1.87202.

Anthelmintic and Hepatoprotective Activities of the Green-Synthesized Zinc Oxide Nanoparticles Against Parascaris equorum Infection in Rats.

Ali S, Mohamed A, Fahmy S, El-Garhy M, Mousa M, Abdel-Ghaffar F Acta Parasitol. 2023; 69(1):283-301.

PMID: 38057445 PMC: 11001740. DOI: 10.1007/s11686-023-00728-4.

References

Yanagisawa N, Morita H, Nakajima T . Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci. 2006; 249(1):76-85. DOI: 10.1016/j.jns.2006.06.007. View

Masson P, Gouet P, Clery C . Pressure and propylene carbonate denaturation of native and "aged" phosphorylated cholinesterase. J Mol Biol. 1994; 238(3):466-78. DOI: 10.1006/jmbi.1994.1305. View

Masson P, Froment M, Darvesh S, Schopfer L, Lockridge O . Aryl acylamidase activity of human serum albumin with o-nitrotrifluoroacetanilide as the substrate. J Enzyme Inhib Med Chem. 2007; 22(4):463-9. DOI: 10.1080/14756360701383932. View

Li H, Schopfer L, Masson P, Lockridge O . Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers. Biochem J. 2007; 411(2):425-32. DOI: 10.1042/BJ20071551. View

Williams N, Harrison J, Read R, Black R . Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agents. Arch Toxicol. 2007; 81(9):627-39. DOI: 10.1007/s00204-007-0191-8. View

Sanghani S, Sanghani P, Schiel M, Bosron W . Human carboxylesterases: an update on CES1, CES2 and CES3. Protein Pept Lett. 2009; 16(10):1207-14. DOI: 10.2174/092986609789071324. View

Darvesh S, MacDonald S, Losier A, Martin E, Hopkins D, Armour J . Cholinesterases in cardiac ganglia and modulation of canine intrinsic cardiac neuronal activity. J Auton Nerv Syst. 1998; 71(2-3):75-84. DOI: 10.1016/s0165-1838(98)00064-2. View

Fleming C, Edwards C, Kirby S, Maxwell D, Potter P, Cerasoli D . Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun. Biochemistry. 2007; 46(17):5063-71. PMC: 2517171. DOI: 10.1021/bi700246n. View

Viragh C, Kovach I, PANNELL L . Small molecular products of dealkylation in soman-inhibited electric eel acetylcholinesterase. Biochemistry. 1999; 38(30):9557-61. DOI: 10.1021/bi991112+. View

10.

Hartmann J, Kiewert C, Duysen E, Lockridge O, Greig N, Klein J . Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity. J Neurochem. 2007; 100(5):1421-9. DOI: 10.1111/j.1471-4159.2006.04347.x. View

11.

Pan Y, Gao D, Yang W, Cho H, Yang G, Tai H . Computational redesign of human butyrylcholinesterase for anticocaine medication. Proc Natl Acad Sci U S A. 2005; 102(46):16656-61. PMC: 1283827. DOI: 10.1073/pnas.0507332102. View

12.

Chatonnet F, Boudinot E, Chatonnet A, Taysse L, Daulon S, Champagnat J . Respiratory survival mechanisms in acetylcholinesterase knockout mouse. Eur J Neurosci. 2003; 18(6):1419-27. DOI: 10.1046/j.1460-9568.2003.02867.x. View

13.

Bolger M, Taylor P . Kinetics of association between bisquaternary ammonium ligands and acetylcholinesterase. Evidence for two conformational states of the enzyme from stopped-flow measurements of fluorescence. Biochemistry. 1979; 18(16):3622-9. DOI: 10.1021/bi00583a029. View

14.

Nomura D, Fujioka K, Issa R, Ward A, Cravatt B, Casida J . Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification. Toxicol Appl Pharmacol. 2008; 228(1):42-8. PMC: 2423230. DOI: 10.1016/j.taap.2007.11.021. View

15.

Adler M, FILBERT M . Role of butyrylcholinesterase in canine tracheal smooth muscle function. FEBS Lett. 1990; 267(1):107-10. DOI: 10.1016/0014-5793(90)80300-8. View

16.

Sanson B, Nachon F, Colletier J, Froment M, Toker L, Greenblatt H . Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime. J Med Chem. 2009; 52(23):7593-603. DOI: 10.1021/jm900433t. View

17.

Shih M, Smith J, McMonagle J, Dolzine T, Gresham V . Detection of metabolites of toxic alkylmethylphosphonates in biological samples. Biol Mass Spectrom. 1991; 20(11):717-23. DOI: 10.1002/bms.1200201111. View

18.

Mahmood N, Carmichael W . Anatoxin-a(s), an anticholinesterase from the cyanobacterium Anabaena flos-aquae NRC-525-17. Toxicon. 1987; 25(11):1221-7. DOI: 10.1016/0041-0101(87)90140-1. View

19.

Huang Y, Lundy P, Lazaris A, Huang Y, Baldassarre H, Wang B . Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin. BMC Biotechnol. 2008; 8:50. PMC: 2415180. DOI: 10.1186/1472-6750-8-50. View

20.

Barak D, Ordentlich A, Bromberg A, Kronman C, Marcus D, Lazar A . Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. Biochemistry. 1995; 34(47):15444-52. DOI: 10.1021/bi00047a008. View